🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn whether CM336, a BCMA/CD3 bispe...
Status
Not Yet Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2026-06-20
Trial ID
NCT07652905
Treatments Being Tested
Primary Objectives: * To evaluate the safety and tolerability of isatuxima...
Status
Completed
Location
~Banner MD Anderson Cancer Center Site Number : 8400005
Start Date
2019-08-06
Trial ID
NCT04045795
The purpose of the study is to determine the best treatment approach based ...
Status
Not Yet Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2026-06-08
Trial ID
NCT07624513
The primary purpose of this study is to assess the efficacy (overall respon...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix- Site Number : 8400058
Start Date
2025-03-17
Trial ID
NCT06356571
The purpose of this clinical trial is to learn how the experimental medicin...
Status
Terminated
Location
Keck Hospital of USC
Start Date
2018-05-14
Trial ID
NCT03530683
The primary objective of this Phase Ib/II trial is to study the safety and ...
Status
Recruiting
Location
University of Wisconsin
Start Date
2026-07
Trial ID
NCT07479979
Treatments Being Tested
This study is to evaluate the combination of isatuximab, iberdomide, bortez...
Status
Not Yet Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2026-06-26
Trial ID
NCT07601100
Treatments Being Tested
The goal of this clinical trial is to learn if anitocabtagene autoleucel fo...
Status
Recruiting
Location
Hospital Germans Trias i Pujol (ICO BADALONA)
Start Date
2025-06-30
Trial ID
NCT07045909
This research study is investigating the safety and effectiveness of using ...
Status
Recruiting
Location
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
Start Date
2022-02-18
Trial ID
NCT05145400
Treatments Being Tested
This study is a single-center, single-arm, open-label, Phase II interventio...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2026-07-25
Trial ID
NCT07585760
Treatments Being Tested